<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The increased cardiovascular risk in <z:mp ids='MP_0002055'>diabetes</z:mp> has been linked to endothelial and <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the role of stable fragments of the precursors of adrenomedullin, endothelin-1, vasopressin, and atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> in progression of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: This was a prospective, observational study design with a composite end point (<z:hpo ids='HP_0011420'>death</z:hpo> or unexpected admission to hospital due to a cardiovascular event) on 781 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (54 events, median duration of observation 15 months) </plain></SENT>
<SENT sid="3" pm="."><plain>The four stable precursor <z:chebi fb="7" ids="16670">peptides</z:chebi> midregional adrenomedullin (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM), midregional proatrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proANP), COOH-terminal proendothelin-1 (CT-proET-1), and COOH-terminal provasopressin or copeptin (CT-proAVP) were determined at baseline, and their association to renal function and cardiovascular events was studied using stepwise linear and Cox logistic regression analysis and receiver operating characteristic analysis, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM, CT-proET-1, CT-proAVP, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proANP were <z:hpo ids='HP_0000001'>all</z:hpo> elevated in patients with future cardiovascular events and independently correlated to serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proANP were significant predictors of a future cardiovascular event, with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proANP being the stronger (area under the curve 0.802 +/- 0.034, sensitivity 0.833, specificity 0.576, positive predictive value 0.132, and negative predictive value 0.978 with a cutoff value of 75 pmol/l) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The four serum markers of vasoactive and natriuretic <z:chebi fb="7" ids="16670">peptides</z:chebi> are related to both kidney function and cardiovascular events, thus linking two major complications of <z:mp ids='MP_0002055'>diabetes</z:mp>, diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>